Teva Must Remove ProAir HFA Device Patents From Orange Book, Judge Orders

A New Jersey federal judge has ordered Teva Pharmaceuticals to remove from the Orange Book five patents on its ProAir HFA asthma inhalation device, clearing the way for Amneal Pharmaceuticals to launch a generic version.
Source: Drug Industry Daily